Bulletin
Investor Alert

New York Markets Close in:

Momenta Pharmaceuticals Inc.

NAS: MNTA

GO
/marketstate/country/us

Market open

 --Real time quotes

Sep 29, 2020, 1:35 p.m.

/zigman2/quotes/200094979/composite

$

52.48

Change

+0.02 +0.04%

Volume

Volume 457,989

Real time quotes

/zigman2/quotes/200094979/composite

Previous close

$ 52.46

$ 52.48

Change

+0.02 +0.04%

Day low

Day high

$52.46

$52.49

Open

52 week low

52 week high

$12.21

$52.49

Open

Alejandra Veronica Carvajal

Alejandra Veronica Carvajal is Secretary, Chief Legal Officer & General Counsel at Momenta Pharmaceuticals, Inc.

In her past career she was Attorney at Hill & Barlow, Inc., Attorney at Day, Berry & Howard LLP and Vice President & General Counsel of Cerulean Pharma, Inc.

Ms. Carvajal received an undergraduate degree from Harvard University and a graduate degree from Georgetown University Law Center.

Transactions

Date Shares Transaction Value
07/20/2020 1,087   Disposition at $33.95 per share. 36,904
07/17/2020 2,437   Derivative/Non-derivative trans. at $0 per share. 0
06/30/2020 6,811   Disposition at $35.1 per share. 239,067
06/29/2020 15,000   Award at $0 per share. 0
06/12/2020 6,756   Disposition at $30.15 per share. 203,694
06/11/2020 15,000   Award at $0 per share. 0
04/20/2020 1,124   Disposition at $28.97 per share. 32,563
04/17/2020 2,438   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2020 5,302   Disposition at $29 per share. 153,758
03/05/2020 15,000   Award at $0 per share. 0
02/14/2020 6,892   Disposition at $31.54 per share. 217,374
02/13/2020 3,108   Disposition at $30.03 per share. 93,334
02/12/2020 10,000   Derivative/Non-derivative trans. at $0 per share. 0
01/22/2020 1,577   Disposition at $28.98 per share. 45,702
01/21/2020 860   Disposition at $30.08 per share. 25,869
01/17/2020 2,437   Derivative/Non-derivative trans. at $0 per share. 0
10/21/2019 6,814   Disposition at $14.4 per share. 98,122
10/18/2019 2,936   Disposition at $13.83 per share. 40,605
10/17/2019 9,750   Derivative/Non-derivative trans. at $0 per share. 0
04/29/2019 10,384   Disposition at $14.77 per share. 153,372
04/13/2019 4,724   0
02/14/2019 703   Disposition at $13.1 per share. 9,210
02/13/2019 2,938   Disposition at $12.7 per share. 37,313
02/12/2019 10,000   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Mr. Bruce L. Downey
Chairman
Mr. Craig A. Wheeler
President, Chief Executive Officer & Director
Dr. Young T. Kwon
Chief Financial & Business Officer
Dr. Santiago Arroyo
Chief Medical Officer & Senior VP-Development
Dr. Anthony M. Manning
Chief Scientific Officer
Mr. Ian D. Fier
Chief Manufacturing & Program Officer
Dr. Jane F. Barlow
Director
Ms. Agnieszka Cieplinska
Chief Accounting Officer
Ms. Patty Eisenhaur
Investor Relations Contact
Ms. Jo-Ann Beltramello
Chief Human Resources & Infrastructure Officer
Ms. Alejandra Veronica Carvajal
Secretary, Chief Legal Officer & General Counsel
Dr. Donna Roy Grogan
Independent Director
Dr. Elizabeth Stoner
Independent Director
Dr. Georges Gemayel
Independent Director
Dr. Jose Carlos Gutiérrez Ramos
Independent Director
Dr. Steven C. Gilman
Independent Director
Link to MarketWatch's Slice.